Back to top
more

Ingevity (NGVT)

(Real Time Quote from BATS)

$40.82 USD

40.82
111,871

+0.42 (1.04%)

Updated Aug 4, 2025 03:36 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (167 out of 246)

Industry: Chemical - Specialty

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Why Is Ingevity (NGVT) Up 6.4% Since Last Earnings Report?

by Zacks Equity Research

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

ICL Group's Earnings Surpass Estimates, Revenues Lag in Q1

by Zacks Equity Research

ICL sees higher sales across its Industrial Products, Phosphate Solutions and Growing Solutions units in Q1.

Zacks Equity Research

Flexible Solutions Earnings and Revenues Miss Estimates in Q1

by Zacks Equity Research

FSI sees lower sales in the first quarter as reduced customer orders led to declines across its segments.

Zacks Equity Research

Koppers Earnings Beat, Revenues Fall Short of Estimates in Q1

by Zacks Equity Research

KOP gains on higher prices and reduced costs in the Railroad and Utility Products and Services segment in the first quarter.

Zacks Equity Research

Innospec's Earnings Surpass Estimates in Q1, Revenues Miss

by Zacks Equity Research

IOSP sees strong results in the Fuel Specialties unit in Q1 with higher margins driving a double-digit year-over-year increase in operating income.

Zacks Equity Research

Ingevity Q1 Earnings Up, Revenues Down Y/Y on Repositioning Actions

by Zacks Equity Research

NGVT's earnings increase, but revenues are impacted by the Performance Chemical segment's repositioning measures.

Zacks Equity Research

Olympic Steel Opens New Facility for Action Stainless Business

by Zacks Equity Research

The New facility is ZEUS' next step in its strategic growth plan for Action Stainless and its entire specialty metals business segment.

Zacks Equity Research

ArcelorMittal Unveils New Share Buyback Program for 2025-2030

by Zacks Equity Research

The new program by MT will involve share repurchases conducted in multiple tranches, with the first tranche allowing for the repurchase of up to 10 million shares.

Zacks Equity Research

Here's Why You Should Hold FMC Stock in Your Portfolio for Now

by Zacks Equity Research

While FMC faces headwinds from pricing pressures and de-stocking, it gains on its efforts to strengthen its product portfolio and restructuring actions.

Zacks Equity Research

Here's Why You Should Retain Reliance Stock in Your Portfolio

by Zacks Equity Research

While RS faces pricing and demand headwinds, it benefits from its resilient business model, strong execution and actions to drive growth through acquisitions.

Zacks Equity Research

BASF Unit Launches First Reduced Carbon Footprint Product

by Zacks Equity Research

BASFY reduces PCF by 10-15% in its newly launched rPCF aroma ingredients portfolio.

Zacks Equity Research

RPM International to Expand Portfolio by Acquiring Star Brands Group

by Zacks Equity Research

RPM is set to diversify offerings and expand market reach for its Rust-Oleum's cleaners business by acquiring a UK-based company. Know more here.

Zacks Equity Research

BASF Expands Portfolio With Sustainable Personal Care Solutions

by Zacks Equity Research

BASFY launches personal care solutions as biodegradable alternatives to traditional products at in-cosmetics Global 2025 held in Amsterdam.

Zacks Equity Research

DuPont Introduces Liveo Pharma TPE Ultra-Low Temp Tubing

by Zacks Equity Research

DD brings Liveo Pharma TPE Ultra-Low Temp Tubing into the market for biopharmaceutical processing applications.

Zacks Equity Research

Here's Why You Should Retain Albemarle Stock in Your Portfolio

by Zacks Equity Research

ALB gains on actions to boost its lithium conversion capacity and productivity actions amid headwinds from softer lithium prices.

Zacks Equity Research

Here's Why You Should Add Ingevity Stock to Your Portfolio

by Zacks Equity Research

NGVT benefits from the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.

Zacks Equity Research

FMC & Bayer Partner to Bring Isoflex Active to European Markets

by Zacks Equity Research

FMC signed a partnership agreement to bring Isoflex Active technology to European markets.

Zacks Equity Research

Reasons Why You Should Hold Nutrien Stock in Your Portfolio Now

by Zacks Equity Research

While NTR faces pricing pressure, it gains on healthy demand for fertilizers, backed by the strength in global agriculture markets.

Zacks Equity Research

Dow and X-Energy Submit Application for Texas Nuclear Project

by Zacks Equity Research

DOW and X-Energy submit permit application to the U.S. Nuclear Regulatory Commission for the construction of SMR project.

Zacks Equity Research

Mosaic's Shares Rise 11% in 3 Months: What's Driving the Stock?

by Zacks Equity Research

MOS benefits from a healthy demand for phosphate and potash, high-return investments and actions to improve its cost structure.

Zacks Equity Research

KWR Acquires Dipsol Chemicals to Boost Portfolio of Advanced Solutions

by Zacks Equity Research

Quaker Chemical is set to offer advanced solutions by using Dipsol's product technologies and its end markets.

Zacks Equity Research

Here's Why You Should Retain Air Products Stock in Your Portfolio

by Zacks Equity Research

While the softness in China and Europe is a concern, APD benefits from its investments in high-return industrial gas projects and productivity actions.

Zacks Equity Research

BASF to Introduce Two Isobionics Natural Flavor Ingredients

by Zacks Equity Research

BASFY employs cutting-edge fermentation technology to produce two new natural ingredients.

Zacks Equity Research

Reliance's Shares Up 11% in 3 Months: What's Driving the Stock?

by Zacks Equity Research

RS benefits from healthy end-market demand, growth through strategic acquisitions and strong liquidity.

Zacks Equity Research

Westlake Epoxy Introduces EpoVIVE Portfolio at ECS 2025

by Zacks Equity Research

WLK unveils a new range of sustainable solutions, EpoVIVE, at ECS 2025.